PBE icon

Invesco Biotechnology & Genome ETF

69 hedge funds and large institutions have $52.3M invested in Invesco Biotechnology & Genome ETF in 2017 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 14 increasing their positions, 16 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
69
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

1 -$1.72M
2 -$547K
3 -$525K
4
Goldman Sachs
Goldman Sachs
New York
-$256K
5
TSS
Two Sigma Securities
New York
-$226K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$7.13M
2
$4.54M
3
$3.81M
4
$3.55M
5
$3.47M
6
$3.09M
7
$2.71M
8
$1.98M
9
$1.71M
10
$1.59M
11
$1.13M
12
$1.1M
13
$1.09M
14
$1.08M
15
$1.05M
16
$975K
17
$844K
18
$831K
19
$782K
20
$767K
21
$721K
22
$688K
23
$606K
24
$529K
25
$505K